 Home > Active Ingredient News > Endocrine System > JAHA: Comparison of hospitalizations of heart failure in diabetic patients with decreased renal function treated with metformin and sulfonylureas

JAHA: Comparison of hospitalizations of heart failure in diabetic patients with decreased renal function treated with metformin and sulfonylureas

 Last Update: 2021-04-17
 Source: Internet
 Author: User

Tags

1 inch 16

80 20 company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Metformin and sulfonylureas are commonly used oral drugs for the treatment of type 2 diabetes .

Metformin diabetic heart failure

Recently, the medsci.

medsci.

The study included new users of metformin or sulfonylurea with an estimated glomerular filtration rate of 60ml/min/1.

The weighted cohort included 24685 metformin-treated patients and 24805 sulfonylurea-treated patients with decreased renal function (median age was 70 years, estimated glomerular filtration rate was 55.

It can be seen that in patients with type 2 diabetes with worsening renal function, compared with sulfonylureas, continuous use of metformin can reduce the rate of hospitalization for heart failure.

In patients with type 2 diabetes with worsening renal function, compared with sulfonylureas, continuous use of metformin can reduce the rate of hospitalizations for heart failure.

Original source:

Tadarro L.

Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort Study

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Empagliflozin

CAS No.: 864070-44-0

Pharmacy Grade

$1134/KG FOB

Yohimbine hydrochloride 98% White crystalline powder

CAS No.: 65-19-0

Pharmacy Grade

$600-620/KG EXW

High Quality Semaglutide 99% powder 910463-68-2-Shaanxi Dideu Medichem Co.Ltd

CAS No.: 910463-68-2

Chemical Grade

$1/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.